As of December 2024, Lixte Biotechnology Holdings has a market cap of $4.72M. This makes Lixte Biotechnology Holdings the world's 5600th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.14M | 16.17% |
2023 | $5.29M | -53.83% |
2022 | $11.45M | -57.23% |
2021 | $26.77M | -62.46% |
2020 | $71.30M | -22.19% |
2019 | $91.64M | -27.03% |
2018 | $125.58M | 463.94% |
2017 | $22.27M | 17.77% |
2016 | $18.91M | -52.51% |
2015 | $39.81M | 22.92% |
2014 | $32.39M | 84.62% |
2013 | $17.54M | -48.00% |
2012 | $33.74M | -50.00% |
2011 | $67.48M | 42.86% |
2010 | $47.24M | -28.57% |
2009 | $66.13M | -14.04% |
2008 | $76.93M | -24.00% |
2007 | $101.22M | - |